# Hagop M. Kantarjian, M.D. - Inspection Records

Source: https://www.keypedia.com/companies/hagop-m-kantarjian-md/57a20198-e024-409a-b67e-d0b49222c3a9

> Inspection records and compliance data for Hagop M. Kantarjian, M.D. in Houston, Texas. Access full analysis and detailed observations.

---

## Details

- Name: Hagop M. Kantarjian, M.D.
- FEI Number: 3003594742
- City: Houston
- State: Texas
- Country Name: United States
- Address Line 1: 1515 Holcombe Blvd Unit 428
- Zip Code: 77030

## Related Documents

- [EIR - Hagop M. Kantarjian, M.D. - 2018-03-16](https://www.keypedia.com/records/eir/hagop-m-kantarjian-md/31c284c1-661c-41cf-9869-4acb3d9f9565) — source: FDA, date: March 16, 2018
- [FDA Inspection 1048237 - Hagop M. Kantarjian, M.D. - 2018-03-16](https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/14b53e31-399f-48c1-8858-b804216afce6) — classification: No Action Indicated (NAI), source: FDA, date: March 16, 2018
- [483 - Hagop M. Kantarjian, M.D. - 2017-05-05](https://www.keypedia.com/records/483/hagop-m-kantarjian-md/ede3cc71-0ef1-46b5-908a-e128be222fff) — source: FDA, date: May 5, 2017
- [FDA Inspection 1029979 - Hagop M. Kantarjian, M.D. - 2017-05-05](https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/08493f8b-285f-4255-ba4d-0475c6e5c680) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 5, 2017
- [FDA Inspection 898289 - Hagop M. Kantarjian, M.D. - 2014-09-17](https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/97d04d3c-c607-401f-a441-1895bf4e7b38) — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2014
- [FDA Inspection 896497 - Hagop M. Kantarjian, M.D. - 2014-09-11](https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/ef4e1ff1-22b5-44f2-ace9-b74d32ebc837) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2014
- [FDA Inspection 746460 - Hagop M. Kantarjian, M.D. - 2011-09-16](https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/28ae3d8d-9664-418a-b943-68907bf72f9e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2011

## Related Companies

- [Azurity Pharmaceuticals, Inc.](https://www.keypedia.com/companies/azurity-pharmaceuticals-inc/be6c2042-21df-4e44-a30d-11c6629303d8)
- [Fujifilm Corporation](https://www.keypedia.com/companies/fujifilm-corporation/6310bc48-89ef-4f36-98c9-1e0294a89e06)
- [Velocity Pharma LLC](https://www.keypedia.com/companies/velocity-pharma-llc/95cf109a-29fe-428d-9b69-52a257c94f0c)
- [Dexcowin Co. Ltd.](https://www.keypedia.com/companies/dexcowin-co-ltd/95b6ec0f-e5d8-4d7d-8eb8-d5d31e4633c5)
- [Inotiv Inc](https://www.keypedia.com/companies/inotiv-inc/be017b67-b3f0-402d-8a03-b124ca114fa6)
- [Meditco, Inc. D.B.A. Phoenicia Specialty Foods](https://www.keypedia.com/companies/meditco-inc-dba-phoenicia-specialty-foods/4296281d-f772-4072-b1de-c83a12281fe2)
- [Syneos Health](https://www.keypedia.com/companies/syneos-health/a2842cea-ef97-4a3d-92be-6af32c00ccaf)
- [Utah Cord Bank LLC](https://www.keypedia.com/companies/utah-cord-bank-llc/743c0464-dbbc-49bb-aa26-68e0f9dc8db6)
- [Reproductive Technologies, Inc.](https://www.keypedia.com/companies/reproductive-technologies-inc/81a46c28-125d-4e9e-ba8b-1d521dff2b44)
- [Advanced Instrumentations, Inc.](https://www.keypedia.com/companies/advanced-instrumentations-inc/4d9b9f1e-df18-4b76-ba69-fbb66b575fc4)

## Related Officers

- [Assistant Country Director, Regulatory Specialist BIMO](https://www.keypedia.com/people/alanna-l-mussawwir-bias/1283ff1a-34dd-4d90-9389-7bff2570527d)
- [company_representative](https://www.keypedia.com/people/monica-i-kwari/2546655d-5b0f-4f97-924d-f31b23f151bb)
- [recipient](https://www.keypedia.com/people/hagop-m-kantarjian/541c9359-7255-40e8-8705-8713c999d646)
